Thiazopyr and Thyroid Disruption: Case Study Within the Context of the 2006 IPCS Human Relevance Framework for Analysis of a Cancer Mode of Action

REFERENCES

• Agrawal A. K., Shapiro B. H. Phenobarbital induction of hepatic CYP2B1 and CYP2B2: Pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose. Mol. Pharmacol. 1996; 49(3)523–31
   PubMedGoogle Scholar
• Bakke J. P. Ames/Salmonella mutagenicity assay with MON 13200: Study no. ML-88–191/EHL no. 88124. Testing facility: Monsanto's Environmental Health Lab (EHL), St. Louis, MO. Submitted by Monsanto, MO, St. Louis 1989a, MRID no. 42275535
   Google Scholar
• Bakke J. P. Evaluation of MON 13200 to Induce Unscheduled DNA Synthesis in the in vitro hepatocyte DNA repair assay in the male F-344 rat: Study no. SR-88-204/SR1 no. LSC 6327. Testing facility: SRI International. Submitted by Monsanto, Menlo Park, CA 1989b, MRID no. 42275538
   Google Scholar
• Bayer I., Mitmaker B., Gordon P. H., Wang E. Modulation of nuclear statin expression in rat thyroid follicle cell following administration of thyroid stimulating hormone. J. Cell. Physiol. 1992; 150: 276–282
   PubMedGoogle Scholar
• Bianco A. C., Salvatore D., Gereben B., Berry M. J., Larsen P. R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 2002; 23(1)38–89
   PubMed Web of Science ®Google Scholar
• Boobis A. R., Cohen S. M., Dellarco V., McGregor D., Meek M.E., Vickers C., Willcocks D., Farland W. IPCS Framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 2006; 36(10)781–792
   PubMed Web of Science ®Google Scholar
• Capen C. C. Mechanisms of chemical injury of thyroid gland. Prog. Clin. Biol. Res. 1994; 387: 173–191
   PubMedGoogle Scholar
• Capen C. C. Toxic responses of the endocrine system. Toxicology: The Basic Science of Poisons, C. D. Klaassen. McGraw-Hill, New York 2001; 711–759
   Google Scholar
• Charles River Laboratories. 2001, http://www.criver.com/techdocs/index.html#normativedata
   Google Scholar
• Curran P. G., DeGroot L. J. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr. Rev. 1991; 12: 135–150
   PubMed Web of Science ®Google Scholar
• Dohler K. D., Wong C. C., Von Zur Muhlen A. The rat as a model for the study of drug effects on thyroid function: Consideration of methodological problems. Pharmacol. Ther. 1979; 5: 305–318
   PubMed Web of Science ®Google Scholar
• Flowers L. J. Micronucleus assay with MON 13200: ML-88–390/EHL study no. 88230. Testing facility: Monsanto's Environmental Health Lab (EHL), St. Louis, MO. Submitted by Monsanto, MO, St. Louis 1990, MRID no. 42275537
   Google Scholar
• Gabriele R., Letizia C., Borghese M., De Toma G., Celia M., Izzo L., Cavalla A. Thyroid cancer in patients with hyperthyroidism. Horm. Res. 2003; 60(2)79–83
   PubMedGoogle Scholar
• Hard G. C. Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis. Environ. Health. Prespect. 1998; 106(8)1–21
   PubMedGoogle Scholar
• Hill R. N., Erdreich L. S., Paynter O. E., Roberts P. A., Rosenthal S. L., Wilkinson C. F. Thyroid follicular-cell carcinogenesis. Fundam. Appl. Toxicol. 1989; 12(4)629–697
   PubMedGoogle Scholar
• Hood A., Liu Y. P., Gattone V. H.II, Klaassen C. D. Sensitivity to thyroid gland growth to thyroid stimulating hormone (TSH) in rats treated with antithyroid drugs. Toxicol. Sci. 1999; 49: 263–271
   PubMed Web of Science ®Google Scholar
• Hotz K. J., Wilson A. G., Thake D. C., Roloff M. V., Capen C. C., Kronenberg J. M., Brewster D. W. Mechanism of thiazopyr-induced effects on thyroid hormone homeostasis in male Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 1997; 142: 133–142
   PubMedGoogle Scholar
• Hurley P. M., Hill R. N., Whiting R. J. Mode of carcinogenic action of pesticides inducing thyroid follicular-cell tumors in rodents. Environ. Health Perspect. 1998; 106(8)437–445
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. In Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis, C. C. Capen, E. Dybing, J. M. Rice, J. D. Wilbourn. IARC Scientific Publication 147, Lyon, France 1999
   Google Scholar
• International Agency for Research on Cancer. Some thyrotropic agents. IARC Monogr. Eval. Carcinogen. Risks Hum. 2001; 79: 763 pages
   Google Scholar
• Li, A.P., Myers C.A. CHO/HGPRST gene mutation assay with MON 13200: Study no. ML-88–382/EHL No. 88071. Testing facility: Monsanto's Environmental Health Lab (EHL), St. Louis, MO. Submitted by Monsanto, MO, St. Louis 1989, MRID no. 42275536
   Google Scholar
• Lichtenstein C. K., Hemminki K. Environmental and heritable cause of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int. J. Cancer. 2002; 1099(2)260–266
   Google Scholar
• Liu J., Liu Y., Barter R. A., Klaassen C. D. Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study. J. Pharmacol. Exp. Ther. 1995; 273: 977–985
   PubMed Web of Science ®Google Scholar
• Masubuchi N., Hakusui H., Okazaki O. Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction. Biochem. Pharmacol. 1997; 54(11)1225–1231
   PubMedGoogle Scholar
• Mazzaferri E. L. Thyroid cancer and Graves’ disease: The controversy ten years later. Endocr. Pract. 2000; 6: 221–225
   PubMedGoogle Scholar
• McClain R. M. Thyroid gland neoplasia: Non-genotoxic mechanisms. Toxicol. Lett. 1992; 64/65: 397–408
   Google Scholar
• McClain R. M. Mechanistic considerations for the relevance of animal data on thyroid neoplasia to human risk assessment. Mutat. Res. 1995; 333(1–2)131–142
   PubMed Web of Science ®Google Scholar
• McClain R. M., Levin A. A., Posch R., Downing J. C. The effect of phenobarbital on the metabolism and excretion of thyroxine in rats. Toxicol. Appl. Pharmacol. 1989; 99: 216–228
   PubMed Web of Science ®Google Scholar
• McMartin D. N., Sahota P. S., Gunson D. E., Hsu H. H., Spaet R. H. Neoplasms and related proliferative lesions in control Sprague-Dawley rats from carcinogenicity studies. Historical data and diagnostic considerations. Toxicol. Pathol. 1992; 20: 212–225
   PubMed Web of Science ®Google Scholar
• Meek M. E., Bucher J. R., Cohen S. M., Dellarco V., Hill R. N., Lehman-McKeeman L. D., Longfellow D. G., Pastoor T., Seed J., Patton D. E. A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol 2003; 33(6)591–654
   PubMed Web of Science ®Google Scholar
• Naylor M. W., Raju N. R. Chronic study of MON 13200 administered in feed to albino mice. Project number ML-88-248/EHL 88147. Testing facility: Monsanto Company, The Agricultural Group, Environmental Health Laboratory, St. Louis, MO. Submitted by: Monsanto Agricultural Company, MO, St. Louis 1992, MRID no. 426197-23
   Google Scholar
• Naylor M. W., McDonald M. M. Chronic study of MON 13200 administered in feed to albino rats: Project number ML-88-247/EHL 88148. Testing facility: Monsanto Company, The Agricultural Group, Environmental Health Laboratory, St. Louis, MO. Submitted by: Monsanto Agricultural Company, MO, St. Louis 1992, MRID no. 426197-24
   Google Scholar
• Olsen J. H., Wallin H., Boice J. D., Rask K., Schulgen G., Fraumaen F. F. Jr. Phenobarbital, drug metabolism and human cancer. Cancer Epidemiol. Biomarkers Prev. 1993; 5: 449–452
   Google Scholar
• Oropeza-Hernandez L. F., Lopez-Romero R., Albores A. Hepatic CYP1A, 2B, 2C, 2E and 3A regulation by methoxychlor in male and female rats. Toxicol Lett. 2003; 144(1)93–103
   PubMedGoogle Scholar
• Ron E., Kleinerman R. A., Boice J. D., LiVolsi V. A., Flannery J. T., Fraumeni J. F. Jr. A population-based case-control study of thyroid cancer. J. Natl. Cancer Inst. 1987; 79: 1–12
   PubMed Web of Science ®Google Scholar
• Rutgers M., Heusdens F. A., Bonthuis F., de Herder W. W., Hazenberg M. P., Visser T. J. Enterohepatic circulation of triiodothyronine (T3) in rats: Importance of the microflora for the liberation and reabsorption of T3 from biliary T3 conjugates. Endocrinology 1989; 125: 2822–2830
   PubMedGoogle Scholar
• Sonich-Mullin C., Fielder R., Wiltse J., Baetcke K., Dempsey J., Fenner-Crisp P., Grant D., Hartley M., Knaap A., Kroese D., Mangelsdorf I., Meek E., Rice J. M., Younes M. IPCS conceptual framework for evaluating a MOA for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 2001; 34: 146–152
   PubMed Web of Science ®Google Scholar
• Sundseth S. S., Waxman D. J. Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. J. Biol. Chem. 1992; 267(6)3915–3921
   PubMedGoogle Scholar
• Thomas G. A., Williams E. D. Thyroid stimulating hormone (TSH)-associated follicular hypertrophy and hyperplasia as a mechanism of thyroid carcinogenesis in mice and rats. Species Differences in Thyroid Gland, Kidney and Urinary Bladder Carcinogenesis, C. C. Capen, E. Dybing, J. M. Rice, J. D. Wilbourn. IARC Publication 147, Lyon 1999; 45–59
   Google Scholar
• U.S. Environmental Protection Agency. Assessment of thyroid-follicular cell tumors. EPA/630/R-97/002. Risk Assessment Forum, Office of Research and Development. U. S. Environmental Protection Agency. Washington, DC 1998, accessed November 22, 2004 http://cfpub.epa.gov/ncea/raf/recordisplay.cfm?deid=13102
   Google Scholar
• Vranckx R., Rouaze-Romet M., Savu L., Mechighel P., Maya M., Nunez E. A. Regulation of rat thyroxine-binding globulin and transthyretin: Studies in thyroidectomized and hypophysectomized rats given tri-iodothyronine or/and growth hormone. J. Endocrinol. 1994; 142: 77–84
   PubMed Web of Science ®Google Scholar